Partícula pseudoviral (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Partícula pseudoviral" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

10doi.org

2^nd place

4^th place

9nih.gov

4^th place

8^th place

2harvard.edu

18^th place

51^st place

1cancer.gov

1,684^th place

1,095^th place

1bbc.com

20^th place

25^th place

1worldcat.org

5^th place

1medpagetoday.com

9,274^th place

low place

bbc.com

Walsh, Fergus (24 de julho de 2015). «Malaria vaccine one step closer». BBC News (em inglês)

cancer.gov

«NCI Dictionary of Cancer Terms». National Cancer Institute (em inglês). 2 de fevereiro de 2011. Consultado em 19 de abril de 2019

doi.org

dx.doi.org

Zeltins A. «Construction and characterization of virus-like particles: a review». Molecular Biotechnology. 53: 92–107. PMC 7090963. PMID 23001867. doi:10.1007/s12033-012-9598-4
Buonaguro L, Tagliamonte M, Tornesello ML, Buonaguro FM. «Developments in virus-like particle-based vaccines for infectious diseases and cancer». Expert Review of Vaccines. 10: 1569–83. PMID 22043956. doi:10.1586/erv.11.135
Mohsen MO, Gomes AC, Vogel M, Bachmann MF. «Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System». Vaccines. 6. 37 páginas. PMC 6161069. PMID 30004398. doi:10.3390/vaccines6030037
Bayer ME, Blumberg BS, Werner B. «Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis». Nature. 218: 1057–9. Bibcode:1968Natur.218.1057B. PMID 4231935. doi:10.1038/2181057a0
Santi L, Huang Z, Mason H. «Virus-like particles production in green plants». Methods. 40: 66–76. PMC 2677071. PMID 16997715. doi:10.1016/j.ymeth.2006.05.020
Huang X, Wang X, Zhang J, Xia N, Zhao Q. «Escherichia coli-derived virus-like particles in vaccine development». NPJ Vaccines. 2. 3 páginas. PMC 5627247. PMID 29263864. doi:10.1038/s41541-017-0006-8
«A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection». Nature Medicine. 16: 334–8. PMC 2834826. PMID 20111039. doi:10.1038/nm.2105
«Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial». The Lancet. 386 (9988): 31–45. Julho de 2015. ISSN 0140-6736. doi:10.1016/s0140-6736(15)60721-8
«Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge». Journal of Virology. 83: 5726–34. PMC 2681940. PMID 19321609. doi:10.1128/JVI.00207-09
Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Fouchier, ed. «Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza». PLOS One. 5: e15559. Bibcode:2010PLoSO...515559L. PMC 3008737. PMID 21203523. doi:10.1371/journal.pone.0015559

harvard.edu

ui.adsabs.harvard.edu

Bayer ME, Blumberg BS, Werner B. «Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis». Nature. 218: 1057–9. Bibcode:1968Natur.218.1057B. PMID 4231935. doi:10.1038/2181057a0
Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Fouchier, ed. «Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza». PLOS One. 5: e15559. Bibcode:2010PLoSO...515559L. PMC 3008737. PMID 21203523. doi:10.1371/journal.pone.0015559

medpagetoday.com

John Gever (12 de setembro de 2010). «ICAAC: High Antibody Titers Seen With Novel Flu Vaccine»

nih.gov

ncbi.nlm.nih.gov

Zeltins A. «Construction and characterization of virus-like particles: a review». Molecular Biotechnology. 53: 92–107. PMC 7090963. PMID 23001867. doi:10.1007/s12033-012-9598-4
Buonaguro L, Tagliamonte M, Tornesello ML, Buonaguro FM. «Developments in virus-like particle-based vaccines for infectious diseases and cancer». Expert Review of Vaccines. 10: 1569–83. PMID 22043956. doi:10.1586/erv.11.135
Mohsen MO, Gomes AC, Vogel M, Bachmann MF. «Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System». Vaccines. 6. 37 páginas. PMC 6161069. PMID 30004398. doi:10.3390/vaccines6030037
Bayer ME, Blumberg BS, Werner B. «Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis». Nature. 218: 1057–9. Bibcode:1968Natur.218.1057B. PMID 4231935. doi:10.1038/2181057a0
Santi L, Huang Z, Mason H. «Virus-like particles production in green plants». Methods. 40: 66–76. PMC 2677071. PMID 16997715. doi:10.1016/j.ymeth.2006.05.020
Huang X, Wang X, Zhang J, Xia N, Zhao Q. «Escherichia coli-derived virus-like particles in vaccine development». NPJ Vaccines. 2. 3 páginas. PMC 5627247. PMID 29263864. doi:10.1038/s41541-017-0006-8
«A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection». Nature Medicine. 16: 334–8. PMC 2834826. PMID 20111039. doi:10.1038/nm.2105
«Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge». Journal of Virology. 83: 5726–34. PMC 2681940. PMID 19321609. doi:10.1128/JVI.00207-09
Landry N, Ward BJ, Trépanier S, Montomoli E, Dargis M, Lapini G, Vézina LP. Fouchier, ed. «Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza». PLOS One. 5: e15559. Bibcode:2010PLoSO...515559L. PMC 3008737. PMID 21203523. doi:10.1371/journal.pone.0015559

worldcat.org

«Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial». The Lancet. 386 (9988): 31–45. Julho de 2015. ISSN 0140-6736. doi:10.1016/s0140-6736(15)60721-8